Company
Headquarters: Shanghai, China
Employees: 3,694
CN¥482.9 Million
CNY as of June 1, 2023
US$66.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. The company produces traditional Chinese medicines, such as capsules, tablets, granules, gels, injections, oral liquids, and others. It provides granules for heart attacks; capsules for diabetes and hyperlipidemia; and others. It is also involved in warehousing and trading businesses. The company was founded in 1996 and is based in Shanghai, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
FUREN Group Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600781 wb_incandescent